<DOC>
	<DOC>NCT00076960</DOC>
	<brief_summary>The purpose of this protocol is to make Stanate (TM) [stannsoporfin, tin-mesoporphyrin] available to infants who meet the following criteria: 1. the infant has a very high level of bilirubin without an adequate clinical response to phototherapy; 2. the infant requires an exchange transfusion; and 3. the family refuses to allow the administration of blood products, particularly on religious grounds, such as within the Jehovah's Witness community.</brief_summary>
	<brief_title>Compassionate Use of Stanate (TM) [Stannsoporfin]</brief_title>
	<detailed_description />
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Jaundice, Neonatal</mesh_term>
	<mesh_term>Tin mesoporphyrin</mesh_term>
	<criteria>Term or near term neonate Elevated serum bilirubin Failing phototherapy Requires exchange transfusion Family refuses exchange transfusion on religious grounds</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Week</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>hyperbilirubinemia</keyword>
	<keyword>jaundice</keyword>
	<keyword>tin-mesoporphyrin</keyword>
	<keyword>stannsoporfin</keyword>
	<keyword>exchange transfusion</keyword>
	<keyword>neonatal hyperbilirubinemia</keyword>
</DOC>